ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 211 out of 2456

$567K Total Retail Price of All Prescriptions

Rank: 176 out of 2456

284 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

31% of this provider’s 284 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 284 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 4,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
LISINOPRIL 439 277 1 1
SIMVASTATIN 439 268 1 2
OMEPRAZOLE 390 127 3 3
OXYCODONE-ACETAMINOPHEN 286 65 S2 4 35
AMLODIPINE BESYLATE 226 148 5 5
METOPROLOL SUCCINATE 223 157 6 13
OXYCODONE HCL 218 25 S2 7 38
CARISOPRODOL 212 43 R 8 179
PROAIR HFA 199 70 9 22
CITALOPRAM HBR 194 89 10 14
SPIRIVA 179 97 11 43
ZOLPIDEM TARTRATE 175 60 12 28
HYDROCODONE-ACETAMINOPHEN 155 49 S3 13 20
LEVOTHYROXINE SODIUM 143 100 14 4
TRAMADOL HCL 135 65 15 24
ADVAIR DISKUS 133 59 16 36
METOPROLOL TARTRATE 131 91 17 10
WARFARIN SODIUM 121 85 18 9
AMPHETAMINE SALT COMBO 118 0 S2 19 275
PREDNISONE 117 72 20 39
PANTOPRAZOLE SODIUM 116 74 21 37
GABAPENTIN 113 42 22 16
METHADONE HCL 98 23 S2 23 135
FENTANYL 97 27 S2 24 115
SERTRALINE HCL 96 59 25 21
LOSARTAN POTASSIUM 96 64 25 18
METFORMIN HCL 93 30 27 11
ATENOLOL 93 57 27 6
DOXYCYCLINE HYCLATE 84 37 29 166
FUROSEMIDE 81 49 30 8
TRAZODONE HCL 79 37 31 17
HYDROCHLOROTHIAZIDE 78 48 32 7
NEXIUM 77 14 33 80
NABUMETONE 72 16 34 164
IBUPROFEN 72 17 34 52
FLUTICASONE PROPIONATE 70 24 36 30
PRAVASTATIN SODIUM 69 54 37 15
VENTOLIN HFA 61 0 38 210
RANITIDINE HCL 60 16 39 31
DONEPEZIL HCL 59 59 40 23
PROCHLORPERAZINE MALEATE 58 0 41 279
CYCLOBENZAPRINE HCL 57 0 R 42 77
TAMSULOSIN HCL 51 35 43 32
GLIPIZIDE 51 40 43 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 3, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.